Article Dec 20, 2024 Advancing EoE Histopathology With Emerging AI Solutions From Alimentiv Disclaimer*The AI-based algorithm for automated PEC developed by Alimentiv is not a medical device and is not used by healthcare professionals for clinical diagnosis or… Read Now
Interview Dec 4, 2024 Spatial Transcriptomics Expertise: An Interview With Dr. Wendy Teft Wendy Teft, PhD, Vice President of Precision Medicine and Head of AcelaBio AcelaBio, Alimentiv’s state-of-the-art specialty laboratory, specializes in delivering high-quality histopathology and precision medicine… Read Now
News May 13, 2024 Alimentiv: A Global GI-Focused CRO with end-to-end clinical trial services and imaging solutions leading with innovation at DDW 2024 London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease… Read Now
Article Mar 19, 2024 Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024 Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide,… Read Now
Article Jan 10, 2024 Bayesian innovations to supplement open-label trials Clinical trials in Crohn’s Disease face additional complexity as biologics provide additional treatment options but may require combination treatments to reach optimal efficacy. A Phase… Read Now
News Jan 8, 2024 Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective… Read Now
Article Nov 9, 2023 2023 Size of the CRO Market We recently published a summary article on the size of the contract research market for the period of 2023 to 2028. We collated data from multiple sources…. Read Now
News Nov 8, 2023 Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials. LONDON, ON, November 8, 2023 – Alimentiv Inc., AcelaBio Inc., and PharmaNest Inc. are pleased to announce their collaborative effort aimed at revolutionizing precision medicine… Read Now
